Company Filing History:
Years Active: 2020
Title: Inventor Profile: Jung-Chen Su
Introduction: Jung-Chen Su is an innovative inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of cancer treatment and lipid metabolism-related diseases. His work emphasizes the importance of adenosine monophosphate-activated protein kinase (AMPK) in regulating various biological processes.
Latest Patents: Jung-Chen Su holds a patent for a compound that acts as an agonist of AMPK. This invention, detailed as an adenosine monophosphate-activated protein kinase agonist, describes a compound formula that induces the phosphorylation and activation of AMPKα. The functionality of this compound plays a crucial role in inhibiting the growth and proliferation of liver and breast cancer cells and inducing apoptosis in adipocytes. The potential applications for this compound are promising, as it can be utilized to develop pharmaceutical compositions aimed at treating cancer and lipid metabolism-related conditions.
Career Highlights: Jung-Chen Su is associated with National Yang Ming Chiao Tung University, where he has been instrumental in advancing research in his field. His innovative approach and dedication have led to the successful development of critical medical applications that address significant health challenges.
Collaborations: Throughout his career, Jung-Chen Su has worked alongside notable researchers, including Chung-Wai Shiau and Yan-Ju Lin. These collaborations have fostered a synergistic environment that promotes groundbreaking discoveries and advancements in medical research.
Conclusion: Jung-Chen Su exemplifies the spirit of innovation in the academic and research spheres. His contributions, particularly his patent on AMPK agonist compounds, reflect the potential to impact medical treatments for cancer and related metabolic disorders. As research continues to evolve, the significance of his work will likely pave the way for future advancements in pharmaceutical compositions.